Anxiety disorders are the most prevalent mental health condition in the United States — the NIMH estimates they affect roughly 19% of US adults in any given year. Yet anxiety is also one of the most undertreated, partly because the presentation varies enormously from person to person, and partly because treatment pathways aren't always clearly communicated. Many people carry a significant anxiety burden for years before seeing a psychiatrist, and many of those years involve self-management, primary care visits, or therapy alone without a medication conversation ever happening.
Telehealth psychiatry has made that conversation more accessible. This article explains how medication management for anxiety works via telehealth, what the main medication classes look like, and what responsible monitoring of anxiety pharmacotherapy actually involves.
Which anxiety disorders are we talking about?
Anxiety is an umbrella term covering several distinct DSM-5-TR diagnoses, each with different evidence bases for medication. The most commonly treated in outpatient psychiatry include:
- Generalized Anxiety Disorder (GAD, ICD-10 F41.1): persistent, difficult-to-control worry across multiple domains, often accompanied by muscle tension, fatigue, difficulty concentrating, and disrupted sleep.
- Panic Disorder (F41.0): recurrent unexpected panic attacks plus significant behavioral change or worry about future attacks.
- Social Anxiety Disorder (F40.10): marked fear of social or performance situations due to anticipated scrutiny.
- Agoraphobia (F40.00) and Specific Phobia (F40.2xx): less commonly managed with medication alone but may be part of a broader treatment plan.
- PTSD (F43.10): overlaps significantly with anxiety presentation; has its own pharmacological treatment guidelines.
The reason the specific diagnosis matters: some medications are approved for some anxiety disorders and not others. Sertraline (Zoloft) is FDA-approved for GAD, panic disorder, social anxiety, and PTSD. Paroxetine covers panic, social anxiety, GAD, and PTSD. Venlafaxine has FDA approval for GAD, social anxiety, and panic disorder. Your psychiatrist will want to clarify diagnosis before recommending a specific agent.
First-line medications: SSRIs and SNRIs
Selective serotonin reuptake inhibitors (SSRIs) are the standard first-line pharmacotherapy for most anxiety disorders. The evidence for SSRIs in GAD, panic disorder, and social anxiety is well-established and consistent across decades of clinical trials. They are generally well tolerated, non-habit-forming, and available as generics at low cost.
Common side effects in the first two to four weeks include nausea, mild insomnia or sedation, and sometimes a transient increase in anxiety symptoms before the therapeutic effect develops. That last point is worth emphasizing: some patients starting an SSRI for anxiety feel briefly more anxious in the first week or two. This is a known pharmacological phenomenon related to the initial serotonin system adjustment, and it typically resolves. If your psychiatrist starts you on an SSRI for anxiety, ask them about this possibility so you're not surprised.
SNRIs like duloxetine and venlafaxine operate similarly but also affect norepinephrine signaling, which may be advantageous for patients whose anxiety has a prominent somatic component (physical symptoms like muscle tension, headaches, gastrointestinal distress). Duloxetine has FDA approval for GAD and is often chosen when there's comorbid pain.
Benzodiazepines: effectiveness, limitations, and honest clinical discussion
Benzodiazepines — including diazepam, lorazepam, alprazolam, and clonazepam — are Schedule IV controlled substances that produce rapid anxiolytic effects by enhancing GABA activity. They're effective in the short term and have a legitimate role in specific clinical situations: acute severe anxiety, panic disorder in the short term while awaiting SSRI effect, and procedural anxiety.
However, they carry real limitations that any responsible psychiatrist will discuss with you. Benzodiazepines do not address the underlying anxiety disorder — they manage the acute symptom. Tolerance develops with regular use, meaning the same dose produces diminishing effect over time. Physical dependence develops, making discontinuation difficult and potentially dangerous if not tapered properly. Cognitive side effects — memory, reaction time, sedation — are meaningful for people who drive, operate machinery, or do cognitively demanding work. In older adults (65+), benzodiazepines are on the Beers Criteria list of medications to avoid due to fall and cognitive risk.
We're not saying benzodiazepines are never appropriate — we're saying that long-term benzodiazepine monotherapy for anxiety is not consistent with current psychiatric treatment guidelines, and a prescriber who starts you on a benzo without a plan for transitioning to an SSRI or addressing the underlying disorder is not giving you complete care. Ask your psychiatrist about their prescribing rationale.
Under the Ryan Haight Act and post-PHE DEA regulations, prescribing Schedule IV benzodiazepines via telehealth follows specific rules. Your telehealth psychiatrist can prescribe benzodiazepines, but they will typically want to ensure appropriate monitoring and may have prescribing policies that require more frequent follow-up for controlled substance management.
Non-benzodiazepine options worth knowing about
Buspirone is an anxiolytic medication that is not a benzodiazepine and is not a controlled substance. It works through serotonin (5-HT1A) and dopamine receptor partial agonism. It's FDA-approved for GAD and has an excellent safety profile — no dependence risk, no sedation at usual doses. Its main limitation is onset: it takes two to four weeks to achieve anxiolytic effect, so it's not useful for acute situational anxiety but works well as a long-term maintenance option.
Hydroxyzine (an antihistamine) is also commonly used for acute anxiety management — it's non-habit-forming, produces mild sedation, and can be used as needed. Propranolol and other beta-blockers are sometimes used for performance anxiety (the physical symptoms: racing heart, tremor) though this is an off-label use for most anxiety indications.
Telehealth medication management: follow-up and monitoring
Starting an anxiety medication via telehealth doesn't mean you're handed a prescription and left to navigate alone. A responsible telehealth psychiatric practice schedules follow-up visits — typically two to four weeks after initiation — to assess tolerability, early response, and dose adequacy. For SSRIs and SNRIs, the therapeutic dose for anxiety may be higher than for depression; your psychiatrist may start low to minimize side effects and titrate upward.
Consider a patient in a suburban area outside Austin who had been managing social anxiety with therapy alone for several years. The therapy helped with coping strategies, but the physiological symptoms — blushing, racing heart, avoidance of work presentations — persisted. After a telehealth evaluation, their psychiatrist started sertraline at 25mg for the first two weeks (to minimize initial side effects), then 50mg, with a follow-up at week four. By week twelve at 100mg, the patient reported meaningful reduction in situational avoidance and was able to present at a team meeting for the first time without pre-emptive panic.
Medication management is not a passive process. It requires honest communication with your psychiatrist about what's working, what isn't, and any side effects you're noticing. Telehealth makes that communication more frequent and lower-barrier — a 15-minute follow-up via video is far more likely to happen than a trip to an in-person office for the same check-in.
Combining medication and therapy
For most anxiety disorders, combined treatment — pharmacotherapy plus evidence-based psychotherapy — outperforms either approach alone. Cognitive behavioral therapy (CBT) and, for panic disorder specifically, exposure-based approaches have strong evidence. Acceptance and Commitment Therapy (ACT) has a growing evidence base for GAD.
Your telehealth psychiatrist manages the medication side of the equation. If you're not currently working with a therapist, they can help you think through options — whether that's a referral to a CBT specialist, an online therapy platform, or an assessment of whether medication alone is a reasonable starting point given your situation. The two modes of treatment are complementary, not competing.